Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Victorian Clinical Genetics Services, |
RCV002472168 | SCV002769228 | uncertain significance | Focal segmental glomerulosclerosis 1 | 2020-10-15 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as 3A-VUS. Following criteria are met: 0103 - Dominant negative and gain of function are suggested mechanisms of disease in this gene and are associated with glomerulosclerosis, focal segmental, 1, (MIM#603278). Functional analysis of missense variants within the binding domain demonstrates they result in both increased actin binding, and impaired wildtype protein localization with downstream consequences such as protein aggregates and inability to stimulate nuclear transcription. Loss of function is also a potential mechanism of disease for variants within the LXXLL motif (PMID: 10700177, PMID: 22351778, PMID: 26740551, PMID: 26301083). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 26301083). 0200 - Variant is predicted to result in a missense amino acid change from isoleucine to arginine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v3) (1 heterozygote, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0601 - Variant is located in the well-established functional calponin homology domain. This region is constrained (Decipher) and functional analysis of missense variants demonstrates impaired protein function (PMID: 10700177). (SP) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |